Eurobio Scientific (ALERS) | Stock Overview & Key Data

What is ALERS's 52-week high and low?

In the last 52 weeks, Eurobio Scientific reached a high of €26.50 (on January 31, 2025) and a low of €13.82 (on July 15, 2024).

What is the market cap and P/E ratio for ALERS?

Curious about Eurobio Scientific's size and valuation? Its market capitalization stands at 253.37M. When it comes to valuation, the P/E ratio (trailing twelve months) is 64.74, and the forward P/E (looking ahead) is 22.75.

Does ALERS pay dividends? If so, what's the yield?

As for dividends, Eurobio Scientific isn't currently offering a significant yield, or that specific data isn't available right now.

Who are Eurobio Scientific's main competitors or similar companies to consider before investing?

When looking at Eurobio Scientific, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Affluent Medical AFME	53.31M	Healthcare	Medical Devices	-13.38%	-60.00%
Carmat S.A ALCAR	24.77M	Healthcare	Medical Devices	-76.25%	-94.75%
Median Technologies ALMDT	25.56M	Healthcare	Medical Devices	-11.85%	-78.67%
Novacyt S.A ALNOV	34.88M	Healthcare	Medical Devices	-17.24%	-64.18%
Diagnostic Medical ALDMS	24.24M	Healthcare	Medical Devices	43.48%	7.32%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Eurobio Scientific S.A.? (e.g., ROE, Debt/Equity)

To get a sense of Eurobio Scientific's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 2.26%, the Debt to Equity ratio from the most recent quarter is 5.46, and its Gross Profit Margin stands at N/A.

What is the recent revenue and earnings growth for ALERS?

Looking at Eurobio Scientific's growth, its revenue over the trailing twelve months (TTM) was €155M. Compared to the same quarter last year (YoY), quarterly revenue grew by 14.30%, and quarterly earnings saw a YoY growth of N/A.

How much of ALERS stock is held by insiders and institutions?

Wondering who owns Eurobio Scientific stock? Company insiders (like executives and directors) hold about 44.37% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 94.01%.

For more common questions about our data, please visit our About Data page.